☰

Two-step ovarian cancer immunotherapy made from patients' own tumor benefits three quarters of trial patients




As many as three quarters of advanced ovarian cancer patients appeared to respond to a new two-step immunotherapy approach -- including one patient who achieved complete remission -- according to new research.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/N...

Domingo, 7 de Abril 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección